Analysts See 900% Upside
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
TCOM Trip.com captured Wall Street attention with 939% analyst upside potential. The $33B Chinese travel platform faces 30% year-to-date losses. Analysts project massive recovery as reopening momentum accelerates.
CYD China Yuchai grabbed second place at 863% upside. The $1.5B machinery maker holds 94 total stock score. The industrial name offers 2% yield showing defensive characteristics.
NOAH Noah Holdings commands 815% return potential per consensus. The $656M wealth manager yields 14.5%. RSI slumped to 30 suggesting oversold territory.
MSFT Microsoft holds 57% upside despite 23% year losses. The $2.8T software giant absorbed fresh analyst conviction. Analysts project recovery from Iran war disruption.
NKE Nike drew analyst support showing 48% upside. The $65B apparel maker plunged 31% year to date. RSI crashed to 20 indicating extreme oversold conditions.
APLS Apellis Pharmaceuticals topped analyst change rankings. The $5.2B biotech surged 61% in 2026. RSI hit 87 showing overbought momentum. Analysts turned negative with minus 4% return outlook.
Chinese names dominated upside lists as valuations reset. US mega caps held analyst support through Middle East volatility.
How this article was generated
- Generated
- 5 Apr 2026, 16:22
- Prompt version
- migrated
- Data sources
- Analyst consensusAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.